578 Ca125, HE4 and systemic immune inflammation index during maintenance with PARPi in ovarian cancer patients: three markers, two markers, or usual ca125? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

Poster and E-Posters

06. Ovarian cancer

578 Ca125, HE4 and systemic immune inflammation index during maintenance with PARPi in ovarian cancer patients: three markers, two markers, or usual ca125?

Authors

Elisa Piovano SCDU Ginecologia e Ostetricia 2U, Ospedale Sant’Anna, AOU Città della Salute e della Scienza di Torino, Torino, Italy PubMed articles Google scholar articles
Fulvio Borella SCDU Ginecologia e Ostetricia 1U, Ospedale Sant’Anna, AOU Città della Salute e della Scienza di Torino, Torino, Italy PubMed articles Google scholar articles
Maria Pia Chiparo Dipartimento di Scienze Chirurgiche, Università degli studi di Torino, Torino, Italy PubMed articles Google scholar articles
Elena Casetta Dipartimento di Scienze Chirurgiche, Università degli studi di Torino, Torino, Italy PubMed articles Google scholar articles
Maria Elena Laudani Dipartimento di Scienze Chirurgiche, Università degli studi di Torino, Torino, Italy PubMed articles Google scholar articles
Stefano Fucina Dipartimento di Scienze Chirurgiche, Università degli studi di Torino, Torino, Italy PubMed articles Google scholar articles
Ylenia Seminara Dipartimento di Scienze Chirurgiche, Università degli studi di Torino, Torino, Italy PubMed articles Google scholar articles
Ida Grimaudo Dipartimento di Scienze Chirurgiche, Università degli studi di Torino, Torino, Italy PubMed articles Google scholar articles
Saverio Danese SC Ginecologia e Ostetricia 4, Ospedale Sant’Anna, AOU Città della Salute e della Scienza di Torino, Torino, Italy PubMed articles Google scholar articles
Elisa Picardo SC Ginecologia e Ostetricia 4, Ospedale Sant’Anna, AOU Città della Salute e della Scienza di Torino, Torino, Italy PubMed articles Google scholar articles
Dionyssios Katsaros SCDU Ginecologia e Ostetricia 1U, Ospedale Sant’Anna, AOU Città della Salute e della Scienza di Torino, Torino, Italy PubMed articles Google scholar articles
Alberto Revelli SCDU Ginecologia e Ostetricia 2U, Ospedale Sant’Anna, AOU Città della Salute e della Scienza di Torino, Torino, Italy PubMed articles Google scholar articles
Stefano Cosma SCDU Ginecologia e Ostetricia 1U, Ospedale Sant’Anna, AOU Città della Salute e della Scienza di Torino, Torino, Italy PubMed articles Google scholar articles
Paolo Zola Dipartimento di Scienze Chirurgiche, Università degli studi di Torino, Torino, Italy PubMed articles Google scholar articles

Citation

Piovano E, Borella F, Chiparo MP, et al

578 Ca125, HE4 and systemic immune inflammation index during maintenance with PARPi in ovarian cancer patients: three markers, two markers, or usual ca125?

International Journal of Gynecologic Cancer 2024;34:A344-A345.

Publication history

First published March 10, 2024.

Online issue publication

March 13, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.